Monthly Archives: May 2013

Pharma Franchises: Promoting Multiple Similar Products to Cut Launch Costs, Leverage Efficiencies

With the “Age of the Blockbuster” on the wane, healthcare companies must find ways to maximize revenue from every corner of their portfolios. Pharma companies large and small are thus under great pressure to cheaply launch and promote each new

Early KOL Development Key to Acceptance

The scientific exchange between medical science liaisons (MSLs) and healthcare professionals and advocates has grown richer and fuller in recent years. This has given Medical Affairs functions greater opportunities to build credibility with Key Opinion Leaders and others that work